SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000930413-23-001180
Filing Date
2023-04-05
Accepted
2023-04-05 08:31:26
Documents
15
Period of Report
2023-04-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 c106144_8k-ixbrl.htm   iXBRL 8-K 20831
2 c106144_ex99-1.htm EX-99.1 10907
3 GRAPHIC x1_c106144a001.jpg GRAPHIC 4590
  Complete submission text file 0000930413-23-001180.txt   181888

Data Files

Seq Description Document Type Size
4 nmtr-20230405_def.xml EX-101.DEF 10976
5 nmtr-20230405_lab.xml EX-101.LAB 20872
6 nmtr-20230405_pre.xml EX-101.PRE 11379
7 nmtr-20230405.xsd EX-101.SCH 3217
9 EXTRACTED XBRL INSTANCE DOCUMENT c106144_8k-ixbrl_htm.xml XML 2546
Mailing Address 4509 CREEDMOOR ROAD SUITE 201 RALEIGH NC 27612
Business Address 4509 CREEDMOOR ROAD SUITE 201 RALEIGH NC 27612 919-275-1933
9 METERS BIOPHARMA, INC. (Filer) CIK: 0001551986 (see all company filings)

IRS No.: 273948465 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37797 | Film No.: 23801255
SIC: 2834 Pharmaceutical Preparations